Search results
Edgewise gets EU orphan drug status for muscular dystrophy drug (NASDAQ:EWTX)
Seeking Alpha· 7 days agoEdgewise Therapeutics (EWTX) has received orphan drug designation from EU regulators for sevasemten...
Fed's Powell, jobs report and Apple will rock markets this week
TheStreet.com· 2 days agoIn addition to economic and earnings news, inflation and geopolitical worries will have roles to play.
Stocks of local interest
Clinton Herald, Iowa via Yahoo Finance· 5 days agoApr. 24—Closing prices Wednesday: Adv Auto Parts 76.53 Abbott Labs 106.89 ADM 61.55 Ameriprise 412.71 AutoZone, Inc. 2,991.30 Boeing 164.33 Bank of America 38.32 BP PLC ADR 39.34 ConAgra Foods ...
AbbVie Q1 Preview: Skyrizi and Rinvoq’s launches could help Q1 (NYSE:ABBV)
Seeking Alpha· 5 days agoAbbVie (ABBV) is set to report Q1 earnings results on April 26th. Analysts expect a profit of $2.26...
BioRestorative Therapies (NASDAQ:BRTX) vs. Global Cord Blood (NYSE:CORBF) Head to Head Comparison
ETF DAILY NEWS· 5 days agoGlobal Cord Blood (NYSE:CORBF – Get Free Report) and BioRestorative Therapies (NASDAQ:BRTX – Get Free Report) are both medical companies, but which is the superior stock?
Biodexa shares rally 126% on rapamycin licensing deal (NASDAQ:BDRX)
Seeking Alpha· 4 days agoBiodexa (BDRX) stock soared 126% Friday after the company announced an exclusive icensing deal to...
Why this is perfect time to buy health-care stocks, one financial advisor says
CNBC· 7 days agoHealth care shouldn't be overlooked as a place to buy amid the current market turmoil, according to...
CPAP Stock Rockets As Quarterly Report Wipes Out Weight-Loss Woes
Investor's Business Daily· 4 days agoResMed is the biggest maker of CPAPs in the U.S., and says the growing popularity of weight-loss...
Immunome appoints oncology expert to board By Investing.com
Investing.com· 5 days agoImmunome, Inc. (NASDAQ:IMNM), a biotechnology firm specializing in targeted cancer therapies, has...
Letter to the editor: Corporate greed and economic inequality
Pittsburgh Tribune-Review· 5 days agoOne is the 1982 SEC ruling to lessen Wall Street rules and regulations, including one on stock buybacks. Between 2015 and 2017 more than half of the total profits earned by ...